WO2005072226A3 - Use of urotensin-ii receptor antagonists in the treatment of inflammatory bowel diseases - Google Patents

Use of urotensin-ii receptor antagonists in the treatment of inflammatory bowel diseases Download PDF

Info

Publication number
WO2005072226A3
WO2005072226A3 PCT/US2005/001791 US2005001791W WO2005072226A3 WO 2005072226 A3 WO2005072226 A3 WO 2005072226A3 US 2005001791 W US2005001791 W US 2005001791W WO 2005072226 A3 WO2005072226 A3 WO 2005072226A3
Authority
WO
WIPO (PCT)
Prior art keywords
urotensin
treatment
inflammatory bowel
receptor antagonists
bowel diseases
Prior art date
Application number
PCT/US2005/001791
Other languages
French (fr)
Other versions
WO2005072226A2 (en
Inventor
Hideo Kikkawa
Hiroshi Kushida
Original Assignee
Smithkline Beecham Corp
Hideo Kikkawa
Hiroshi Kushida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Hideo Kikkawa, Hiroshi Kushida filed Critical Smithkline Beecham Corp
Publication of WO2005072226A2 publication Critical patent/WO2005072226A2/en
Publication of WO2005072226A3 publication Critical patent/WO2005072226A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.
PCT/US2005/001791 2004-01-19 2005-01-18 Use of urotensin-ii receptor antagonists in the treatment of inflammatory bowel diseases WO2005072226A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53764604P 2004-01-19 2004-01-19
US60/537,646 2004-01-19

Publications (2)

Publication Number Publication Date
WO2005072226A2 WO2005072226A2 (en) 2005-08-11
WO2005072226A3 true WO2005072226A3 (en) 2006-04-20

Family

ID=34825934

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/001791 WO2005072226A2 (en) 2004-01-19 2005-01-18 Use of urotensin-ii receptor antagonists in the treatment of inflammatory bowel diseases

Country Status (1)

Country Link
WO (1) WO2005072226A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200804347A (en) 2006-01-10 2008-01-16 Janssen Pharmaceutica Nv Urotensin II receptor antagonists
CA2659412A1 (en) 2006-07-31 2008-02-07 Janssen Pharmaceutica N.V. Urotensin ii receptor antagonists
JP2011529966A (en) 2008-08-02 2011-12-15 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Urotensin II receptor antagonist

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002008972A2 (en) * 2000-07-21 2002-01-31 Hewlett-Packard Company Method and apparatus for automated on-line printing service
US6428982B1 (en) * 1999-06-07 2002-08-06 Smithkline Beecham Corporation Polynucleotides encoding mouse urotensin-II Receptor (UTB-R)

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428982B1 (en) * 1999-06-07 2002-08-06 Smithkline Beecham Corporation Polynucleotides encoding mouse urotensin-II Receptor (UTB-R)
WO2002008972A2 (en) * 2000-07-21 2002-01-31 Hewlett-Packard Company Method and apparatus for automated on-line printing service

Also Published As

Publication number Publication date
WO2005072226A2 (en) 2005-08-11

Similar Documents

Publication Publication Date Title
WO2004073634A3 (en) Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
WO2006124748A3 (en) Multicyclic compounds and methods of their use
TWI347844B (en) Sulfoximine-substituted pyrimidines as cdk-and/or vegf inhibitors, their production and use as pharmaceutical agents
TWI340138B (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
ZA200709430B (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2007007173A3 (en) Human anti-madcam antibodies
GEP20125565B (en) Lactam compounds and their pharmaceutical use
ITRM20050265A1 (en) MODULAR PROSTHESIS REFINED FOR OSTEOSYNTHESIS, IN PARTICULAR FOR THE OSTEOSYNTHESIS OF THE HUMERUS.
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
WO2006004741A3 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
EP1904021A4 (en) Low viscosity, unstable water-in-silicone emulsion cosmetic compositions and methods of use thereof
WO2007050802A3 (en) Novel opioid antagonists
WO2006004684A3 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
WO2006116221A3 (en) Therapeutic combinations for the treatment or prevention of psychotic disorders
IL183928A0 (en) Bcma polypeptides, their preparation and pharmaceutical compositions containing them
IL209879A0 (en) Substituted pteridines ,pharmaceutical compositions containing them and their use in the manufacture of medicaments for treating inflammatory diseases
TW200745081A (en) Compounds
MXPA03010158A (en) Sulfonamides.
WO2006135694A3 (en) Uii-modulating compounds and their use
WO2008112325A3 (en) Treatment of autoimmune disorders
MX2007001876A (en) Vla-4 antagonists.
WO2007134118A3 (en) Protein based composition and methods of using same
PL1791872T3 (en) Biotinylated hexadecasaccharides, pharmaceutical compositions and use thereof
ATE524463T1 (en) 4-CHROMENONYL-1,4-DIHYDROPYRIDINE CARBONITRILES AND THEIR USE
WO2004089313A3 (en) Novel olanzapine forms and related methods of treatment

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase